Overall rank by patents
#4,728
of 49,997 tracked assignees
USPTO PatentsView assignee record - 74 granted patents across 23 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).
The verdict
According to USPTO PatentsView, Molecular ranks #4,728 of 49,997 tracked US assignees by granted-patent volume, with 74 patents across 23 technology areas.
USPTO PatentsView assignee plate
Corpus R4728 · US Corporation #4,728 · 74 grants
GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL
Nearest grant-volume peer: Kaohsiung Medical University (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Axcelis · near
48 score
Columbia Sportswear… · near
48 score
Intra-cellular… · near
48 score
Molecular Devices · this assignee
48 score
The Stanley Works… · near
48 score
3D Lighting… · lowest
7 score
What this shows Molecular's Innovation Score is 48.4/100 (top 17% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Molecular Devices, LLC is a focused PatentsView assignee: 23 CPC subclasses with 54.1% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2018 (11 grants) versus a trough of 3 in 2016. By volume, Molecular sits between Kaohsiung Medical University and Pierburg GMBH.
From 2019–2021 to 2022–2024, Molecular Devices, LLC moved from 23 to 19 grants (0.83x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Kaohsiung Medical University
74 patents
Keystone Retaining Wall Systems, LLC
74 patents
Luigi Lavazza S.p.A.
74 patents
Magnolia Medical Technologies, Inc.
74 patents
Nanning FuLian FuGui Precision Industrial Co., Ltd.
74 patents
NcStar, Inc.
74 patents
Physik Instrumente (PI) GMBH & Co. KG
74 patents
Pierburg GMBH
74 patents
Molecular Devices, LLC
74 patents
What this shows Molecular holds 74 patents at rank #4,728, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #4,728 in granted patent volume.
Other assignees with the most granted patents in Molecular's primary technology class.
Two PlainPatent-derived peer sets for Molecular, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (48 here).
Nearest assignees by average claims per patent (18.3 here).
Molecular's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
48 Top 17% higher than 83% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 10 | 13.5% |
| 2016 | 3 | 4.1% |
| 2017 | 6 | 8.1% |
| 2018 | 11 | 14.9% |
| 2019 | 5 | 6.8% |
| 2020 | 8 | 10.8% |
| 2021 | 10 | 13.5% |
| 2022 | 5 | 6.8% |
| 2023 | 7 | 9.5% |
| 2024 | 7 | 9.5% |
| 2025partial year | 2 | 2.7% |
Top 15 of 23 technology areas
Overall rank by patents
#4,728
of 49,997 tracked assignees
48.4 out of 100
What to do with this data
Molecular Devices, LLC's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.